BL
ERNAW

Bleichroeder LP’s Ernexa Therapeutics Warrants ERNAW Stock Holding History

Bleichroeder LP’s Portfolio ERNAW Stock Details ERNAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$143K Hold
2,000,000
– – 0.03% 64
2026
Q1 		$56K Buy
+2,000,000
New +$118K 0.01% 68

Other funds holding ERNAW

HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Bleichroeder LP's ERNAW Position: Q2 2026 in Review

Bleichroeder LP held its Ernexa Therapeutics Warrants (ERNAW) position steady in Q2 2026 at 2,000,000 shares worth $143K. The position accounts for 0.03% of the portfolio, ranked #64.

Bleichroeder LP first reported a position in ERNAW in Q1 2026 and has held it in 2 quarters since. 6 funds tracked by Wall St. Rank hold ERNAW as of Q2 2026.

  • Bleichroeder LP held 2,000,000 shares of Ernexa Therapeutics Warrants worth $143K as of Q2 2026.
  • Bleichroeder LP left its Ernexa Therapeutics Warrants share count unchanged in Q2 2026.
  • Ernexa Therapeutics Warrants made up 0.03% of Bleichroeder LP's portfolio in Q2 2026, its #64 holding.
  • Bleichroeder LP first reported a position in Ernexa Therapeutics Warrants in Q1 2026 and has held it in 2 quarters since.
  • 6 funds tracked by Wall St. Rank held Ernexa Therapeutics Warrants as of Q2 2026.

Based on Bleichroeder LP's 13F filing for Q2 2026, filed 13 Aug 2026.